PATENT CLAIM ANALYSIS

Application Number: 15950539
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Claim (Index 30):
The method of  claim 27 , wherein the nanoparticulate pharmaceutical dosage form is administered intramuscularly to the human.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15437534', '15950367', '10784900', '15130255', '15130331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7659669510275696
- 35 USC 102 Novelty (BERT): 0.5326143429345501
- Combined Prediction Score: 0.7426316902182677
- Mean Citation Score: 310.536418
- Max Citation Score: 365.674
- Similarity Product: 221.91259012484548

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test